{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:03:45Z","timestamp":1790597025281,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The incidence of end-stage renal disease (ESRD) caused by renal cell carcinoma (RCC) is increasing with the high prevalence of RCC as well as those with treatment-related renal function impairment. Worries about tumor recurrence after transplant-related immunosuppression hinder the recommendation of kidney transplantation for RCC-induced ESRD patients. However, no direct analysis has been performed to identify whether kidney transplantation can offer better survival than maintaining dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective population-based cohort study was based on Organ Procurement and Transplantation Network data released in March 2021. Characteristics and outcomes were compared, including the patient and graft survival of candidates and recipients with RCC-induced ESRD etiology as well as other primary diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with RCC-induced ESRD were older; more likely to be male, White, and obese; and more likely to have a history of diabetes and dialysis. They also had higher creatinine levels, more delayed graft function, more primary non-function, and higher Kidney Donor Profile Index score donors, compared with the glomerulonephritis (GN) group. While waiting, RCC candidates suffered the worst outcomes of all groups, a 44% (adjusted hazard ratio [aHR], 1.44 [1.27\u20131.62]) higher risk of removal than GN patients. After transplantation, RCC recipients demonstrated comparable patient survival and better graft survival (p=0.21 and p=0.13, respectively). Compared with still-waiting RCC patients, the RCC recipients who received kidney transplants had significantly better outcomes (13.6 [9.3\u201317.8] vs. 61 [52\u201368.4] %), decreasing the death or deteriorating risk by 84% (aHR, 0.16 [0.13\u20130.20]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with RCC-induced ESRD can dramatically benefit from kidney transplantation. Hence, these patients should not be limited to transplantation by strict strategies or a delayed waiting time out of their malignancy history.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2022.955771","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T10:10:27Z","timestamp":1664446227000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Transplant or dialysis: What\u2019s the better choice for RCC-induced ESRD patients? A 20-year analysis of OPTN\/UNOS data"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaowei","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinze","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jama.292.1.97","article-title":"Renal cell carcinoma","volume":"292","author":"Curti","year":"2004","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.07.004","article-title":"Guideline for management of the clinical T1 renal mass","volume":"182","author":"Campbell","year":"2009","journal-title":"J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: Results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.03.023","article-title":"End-stage renal disease after renal surgery in patients with normal preoperative kidney function: Balancing surgical strategy and individual disorders at baseline","volume":"70","author":"Capitanio","year":"2016","journal-title":"Eur Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.2341","article-title":"Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation","volume":"36","author":"Sanchez","year":"2018","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11941116","article-title":"Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: A systematic review and meta-analysis","volume":"12","author":"Patel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.04.081","article-title":"Management of renal masses and localized renal cancer: Systematic review and meta-analysis","volume":"196","author":"Pierorazio","year":"2016","journal-title":"J Urol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002178","article-title":"Solid organ transplantation in patients with preexisting malignancies in remission: A propensity score matched cohort study","volume":"102","author":"Acuna","year":"2018","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2010.09.003","article-title":"Epidemiology of chronic kidney disease in cancer patients: Lessons from the IRMA study group","volume":"30","author":"Launay-Vacher","year":"2010","journal-title":"Semin Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trre.2005.02.002","article-title":"Transplant recipients with a history of a malignancy: Risk of recurrent and de novo cancers","volume":"19","author":"Kauffman","year":"2005","journal-title":"Transplant Rev"},{"key":"B14","article-title":"Evaluation of transplant candidates with pre-existing malignancies","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001192","article-title":"Outcomes of solid organ transplant recipients with preexisting malignancies in remission: A systematic review and meta-analysis","volume":"101","author":"Acuna","year":"2017","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40620-018-0542-y","article-title":"Kidney transplantation in patients with previous renal cancer: A critical appraisal of current evidence and guidelines","volume":"32","author":"Frasc\u00e0","year":"2019","journal-title":"J Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)6029-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6051.21.04583-3","article-title":"Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: A systematic review","volume":"74","author":"Campi","year":"2022","journal-title":"Minerva Urol Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16324","article-title":"Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13620","article-title":"Renal fossa recurrence after nephrectomy for renal cell carcinoma: Prognostic features and oncological outcomes","volume":"119","author":"Psutka","year":"2017","journal-title":"BJU Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(05)67350-8","article-title":"Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy","volume":"164","author":"Itano","year":"2000","journal-title":"J Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2020.08.002","article-title":"Renal cell carcinoma: the role of radical surgery on different patterns of local or distant recurrence","volume":"35","author":"Di Franco","year":"2020","journal-title":"Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.01.043","article-title":"Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma","volume":"181","author":"Margulis","year":"2009","journal-title":"J Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2019.06.001","article-title":"Impact of pre-transplant malignancy on outcomes after kidney transplantation: United network for organ sharing database analysis","volume":"229","author":"Livingston-Rosanoff","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-015-0219-8","article-title":"Renal cancer in kidney transplanted patients","volume":"28","author":"Frasc\u00e0","year":"2015","journal-title":"J Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.03.032","article-title":"Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients","volume":"186","author":"Leveridge","year":"2021","journal-title":"J Urol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6051.20.04151-X","article-title":"Robot-assisted partial nephrectomy: 7-year outcomes","volume":"73","author":"Carbonara","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002154","article-title":"The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the transplantation center Munich","volume":"71","author":"Wimmer","year":"2007","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.03.007","article-title":"An instrumental variable approach confirms that the duration of pretransplant dialysis has a negative impact on the survival of kidney transplant recipients and quantifies the risk","volume":"96","author":"Fu","year":"2019","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08817.x","article-title":"Renal cell carcinoma in patients with end-stage renal disease: Relationship between histological type and duration of dialysis","volume":"105","author":"Nouh","year":"2010","journal-title":"BJU Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.12.042","article-title":"Challenges in the counseling and management of older kidney transplant candidates","volume":"47","author":"Danovitch","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001002","article-title":"Survival benefit in renal transplantation despite high comorbidity","volume":"100","author":"S\u00f8rensen","year":"2016","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068769","article-title":"Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: Systematic review and meta-analysis","volume":"376","author":"Chaudhry","year":"2022","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.3389\/fonc.2026.2000045","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.955771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:26:37Z","timestamp":1790594797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.955771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":36,"alternative-id":["10.3389\/fonc.2022.955771"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.955771","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"955771"}}